ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Olema Pharmaceuticals Inc

Olema Pharmaceuticals Inc (OLMA)

11.32
0.12
(1.07%)
At close: March 28 04:00PM
11.32
0.12
( 1.07% )
After Hours: 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
11.32
Bid
11.00
Ask
11.74
Volume
499,208
10.79 Day's Range 11.50
3.00 52 Week Range 17.7911
Market Cap
Previous Close
11.20
Open
11.21
Last Trade
1
@
11.74
Last Trade Time
18:08:14
Financial Volume
$ 5,603,583
VWAP
11.2249
Average Volume (3m)
831,995
Shares Outstanding
55,914,741
Dividend Yield
-
PE Ratio
-6.04
Earnings Per Share (EPS)
-1.87
Revenue
-
Net Profit
-104.79M

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has c... Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Olema Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker OLMA. The last closing price for Olema Pharmaceuticals was $11.20. Over the last year, Olema Pharmaceuticals shares have traded in a share price range of $ 3.00 to $ 17.7911.

Olema Pharmaceuticals currently has 55,914,741 shares outstanding. The market capitalization of Olema Pharmaceuticals is $632.95 million. Olema Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.04.

OLMA Latest News

Form S-8 - Securities to be offered to employees in employee benefit plans

As filed with the Securities and Exchange Commission on March 11, 2024   Registration No. 333-     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

--12-310001750284falseFYCA0001750284us-gaap:ShareBasedPaymentArrangementEmployeeMemberolma:EquityIncentivePlan2020Memberus-gaap:PerformanceSharesMember2022-11-012022-11-300001750284olma:BioMedicalR...

Form 8-K - Current report

false000175028400017502842024-03-112024-03-11   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to...

Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

Presented compelling clinical results for palazestrant both as a monotherapy and in combination with CDK4/6 inhibitors, ribociclib and palbociclib, in Q4 2023 Initiated OPERA-01 pivotal Phase 3...

Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors

Data published in Molecular Cancer Therapeutics describes the scientific background underlying the design, discovery and optimization of palazestrant (OP-1250)Pre-clinical results demonstrate that...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...

Form 144 - Report of proposed sale of securities

="/Images/box-unchecked.jpg" alt="Checkbox not checked">2500003/20/2007Cash* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.5-4.2301184433211.8211.8510.7871214911.22322343CS
4-1.8-13.719512195113.1215.3210.65112068012.17324261CS
12-2.36-17.251461988313.6816.77510.6583199512.76834805CS
26-1.76-13.455657492413.0817.79119.9679893213.04642545CS
527.88229.0697674423.4417.7911355995911.71051136CS
156-19.33-63.066884176230.6536.7242079111.68593227CS
260-35.68-75.9148936174760.27239395113.12052699CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.02
(47.85%)
2.82M
SBFMSunshine Biopharma Inc
$ 0.0754
(24.63%)
24.9M
GRTXGalera Therapeutics Inc
$ 0.1731
(23.64%)
1.09M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.41k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.66
(-33.34%)
1.25M
NDRAENDRA Life Sciences Inc
$ 0.47
(-18.97%)
129.24k
KYCHKeyarch Acquisition Corporation
$ 10.00
(-18.70%)
9.44k
NVVENuvve Holding Corporation
$ 0.90
(-18.18%)
137.23k
APLTApplied Therapeutics Inc
$ 5.65
(-16.91%)
275.1k
SBFMSunshine Biopharma Inc
$ 0.0754
(24.63%)
24.9M
CRKNCrown Electrokinetics Corporation
$ 0.062
(3.51%)
6.94M
AAPLApple Inc
$ 171.269
(-0.12%)
3.56M
JAGXJaguar Health Inc
$ 0.0868
(-3.45%)
3.17M
GMDAGamida Cell Ltd
$ 0.0376
(4.16%)
3.1M

Your Recent History

Delayed Upgrade Clock